Results 51 to 60 of about 5,794,212 (304)

Unraveling the Worth of a Clinical Pharmacist

Indian Journal of Critical Care Medicine, 2021
Krishna B. Unraveling the Worth of a Clinical Pharmacist. Indian J Crit Care Med 2021;25(11):1215-1216.
openaire   +2 more sources

Abatacept for Prophylaxis of Acute and Chronic Graft‐Versus‐Host‐Disease in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation—A Systematic Review and Meta‐Analysis of Cohort Studies

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Graft‐versus‐host disease (GvHD) remains one of the most significant complications of hematopoietic stem cell transplantation (HSCT). Abatacept, a selective T‐cell costimulation modulator, is a relatively novel prophylactic agent, though pediatric data remain limited.
Matthijs D. Kruizinga, Anne B. Verbeek, Caroline A. Lindemans, Emilie P. Buddingh   +3 more
wiley   +1 more source

A Veterans Affairs' perspective in response to Best Practice Model Subcommittee attribute statements for outpatient psychiatric pharmacists [PDF]

Mental Health Clinician, 2022
Jonathan F. Lister, PharmD, BCPP, Dana Chiulli, PharmD, BCPP, Sarah E. Ward, PharmD, BCPP, Erica Frazier, PharmD, BCPP   +3 more
doaj   +1 more source

Clinical experience and treatment considerations with vesicular monoamine transport 2 inhibitors [PDF]

Mental Health Clinician
Vesicular monoamine transporter 2 inhibitors (VMAT2i) are currently Food and Drug Administration–approved for the treatment of Huntington disease chorea and tardive dyskinesia.
Kayla Johnson, PharmD, BCPS, BCPP
doaj   +1 more source

Bone and Soft Tissue Neoplasms in Infants Versus Older Children: A Report From the Cancer in Young People in Canada Program

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background and Aims Infant bone and soft tissue neoplasms present distinct clinical challenges and lack large‐scale data to inform treatment decisions. This study aims to characterize bone and soft tissue neoplasms in infants in Canada and to compare their outcomes with those of older pediatric patients.
Samuel Sassine, Hallie Coltin, Maria Kondyli, Monia Marzouki, Nicolas Prud'homme, Nida Usmani, Rebecca J. Deyell, Lesleigh Abbott, Tony H. Truong, Sapna Oberoi, Ketan Kulkarni, Josée Brossard, Lynette Bowes, Paul Gibson, Sarah McKillop, Roona Sinha, Lillian Sung, Catherine Vezina, Laura Wheaton, Alexandra P. Zorzi, Marie‐Claude Pelland‐Marcotte, Thai Hoa Tran   +21 more
wiley   +1 more source

Identification of drug-related problems by a clinical pharmacist in addition to computerized alerts

, 2013
Background Both clinical pharmacists and computerized physician order entry systems with clinical decision support (CPOE/CDSS) can reduce drug-related problems (DRPs).
C.C., Tijssen, Zaal, R.J., Roukema, J.A., Jansen, M., van den Bemt, P.M., Duisenberg-van Essenberg, M.   +5 more
core   +1 more source

Impact of Initial Treatment Setting on Survival in Relapsed Pediatric and AYA Bone Sarcomas: A Secondary Analysis of a Prospective Clinical Trial

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Outcomes in relapsed or refractory pediatric and AYA bone sarcomas remain poor, and the impact of early referral to specialized sarcoma centers on survival is unclear. Early centralization of care may improve local and systemic treatment quality, but evidence in this population is limited.
Justyna Antoniuk‐Majchrzak, Katarzyna Bilska, Tomasz Koziński, Jadwiga Węcławek‐Tompol, Dorota Sega‐Pondel, Radosław Chaber, Wanda Badowska, Katarzyna Rosłan, Hanna Koseła‐Paterczyk, Anna Raciborska   +9 more
wiley   +1 more source

The value of the clinical pharmacist interventions on applying the 2018 ACC/AHA guideline recommendations.

, 2023
The value of the clinical pharmacist interventions on applying the 2018 ACC/AHA guideline recommendations.
Khozama AlAhmad (14846174), Salah AbuRuz (12184413), Mohammad M. AlAhmad (14846171), Sham ZainAlAbdin (12184416), Iqbal AlAhmad (14846177)   +4 more
core   +1 more source

Board-certified psychiatric pharmacists in substance use disorder treatment: Integration, services, and outcomes across care settings [PDF]

Mental Health Clinician
Introduction At present, there is a shortage of clinicians providing substance use disorder (SUD) treatment, thereby limiting access to evidence-based care.
Anuja Vallabh, PharmD, BCPP, Audrey Abelleira, PharmD, BCPP, Amber R. Douglass, PharmD, BCPS, BCPP, FAAPP, Cynthia A. Gutierrez, PharmD, MS, BCPP, Ashley Maister, PharmD, BCPP, Benjamin Miskle, PharmD, Karen E. Moeller, PharmD, BCPP, Aaron Salwan, PharmD, MPH, BCPP, Kristin Waters, PharmD, BCPP, BCPS, David Dadiomov, PharmD, BCPP   +9 more
doaj   +1 more source

Lorlatinib‐Containing Therapy for MYCN‐Amplified, ALK‐Mutated Neuroblastoma With Bulky Leptomeningeal Relapse: A Case Report

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Central nervous system (CNS) relapse of neuroblastoma carries a poor prognosis, and craniospinal irradiation (CSI) poses substantial long‐term toxicity in young children. We report a toddler with MYCN‐amplified neuroblastoma harboring somatic ALK R1275Q who developed extensive leptomeningeal relapse with paraplegia.
Jinwoo Kim, Minji Kim, Nani Jung, Sung Eun Kim, Ji Yoon Kim, Mi Ae Chu, Jung Eun Kwon, Yeo Hyang Kim, So Mi Lee, Ki‐Su Park, Jeong Eun Lee, Ye Jee Shim   +11 more
wiley   +1 more source